BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Meeting05-02-2021
05-02-2021
Biocon Biologics inks pact to expand access to its cancer biosimilars
Biocon Biologics is an arm of biotechnology major Biocon04-02-2021
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries, Will enable access to Trastuzumab & Pegfilgrastim in Africa & Asia04-02-2021
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Meeting04-02-2021
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Meeting03-02-2021
Neutral Biocon; target of Rs 385: Motilal Oswal
Motilal Oswal recommended Neutral rating on Biocon with a target price of Rs 385 in its research report dated January 22, 2021.02-02-2021
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Meeting02-02-2021
Buy Biocon; target of Rs 470: Sharekhan
Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 470 in its research report dated January 22, 2021.01-02-2021
Women's economic empowerment vital to tackle gender inequality: Biocon head
Economic empowerment of women is extremely important to bridge the gap of gender inequality,US-India Business Council Vice Chair and Biocon Executive Chair Kiran Mazumdar-Shaw said on Thursday. Speaking at a virtual event on 'Expanding the US-India Partnership: Promoting Gender Diversity at Work', she said gender inequality starts with the skewed distribution that women face when it comes to the distribution of assets or inheritance or workplace employment or representation in socio-political institutions. "Economic empowerment is what will bridge the gap of gender inequality. I think economic empowerment of the women is extremely important," Mazumdar-Shaw said. Even in the corporate world, there is a lot of tokenism in everything we do, she said. Of the top 100 BSE companies in India, 91 have only one woman director, which means it is just sort of ticking a box. Moreover, when they want to find a woman for the board, it is the same group of women they are looking at. The canvas ha28-01-2021
Hold Biocon; target of Rs 450: ICICI Direct
ICICI Direct recommended hold rating on Biocon with a target price of Rs 450 in its research report dated January 22, 2021.28-01-2021